Neuroprotective Potential of GLP-1 Receptor Agonists in Neurodegenerative Diseases: Narrative Review
Abstract Background Neurodegenerative disorders, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD), present substantial global health challenges due to a lack of disease-modifying therapies. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), traditionally used in type 2 diabetes management, have em...